OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
22/03/2025
Voltar para busca
Dado oficial do USPTO
CORDEN PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
03/04/2026
Tipo de marca
Mista
Classes Nice
40, 42
Data de depósito
25/08/2023
Data de registro
17/09/2024
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/09/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
RADEMACHER, APRIL LUEDERS
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording CORDEN PHARMA in blue to the right of a stylized double helix where the left side is blue and the right side is green.
Titulares e representantes
Titulares
Corden Pharma International GmbH
Representantes
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Classificação técnica
Classes Nice
Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Custom manufacture of pharmaceutical products; treatment of chemical products; recycling of chemical products
Classe 42
Pharmaceutical research services; qualitative evaluation of pharmaceutical products; development of pharmaceutical products; inspection of pharmaceutical products; research in the field of pharmaceutical products; testing on pharmaceutical products; pharmaceutical product development services; development of pharmaceutical preparations and medicines; laboratory research services concerning pharmaceutical products; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; provision of information concerning the results of clinical trials for pharmaceutical products; industrial packaging design services; chemical laboratory services; chemical engineering services; chemical analysis; chemical research; testing of chemical products; chemical technology research; analysis of the chemical composition of liquids; evaluation of chemical information to estimate risk levels
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
15/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/02/2025
FIMP
FINAL DISPOSITION PROCESSED
25/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
20/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
PUBO
PUBLISHED FOR OPPOSITION
02/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/06/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/05/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/05/2024
RFNT
REFUSAL PROCESSED BY IB
22/05/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/04/2024
RFRR
REFUSAL PROCESSED BY MPU
26/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/04/2024
CNRT
NON-FINAL ACTION WRITTEN
12/04/2024
DOCK
ASSIGNED TO EXAMINER
23/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
17/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CORDEN PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.